Topical Azithromycin and oral doxycycline in meibomian gland dysfunctio

Not Applicable

• Conditions: H01.0; Meibomian gland dysfunction.; Blepharitis

• Registration Number: IRCT20220607055097N3
• Lead Sponsor: owshera Medical College/ Qazi Hussain Ahmad Medical Complex

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All the patients within the specified age group with posterior blepharitis secondary to meibomian gland dysfunction
Patients with meibomian gland dysfunction, non responsive to conventional therapy such as lid massage, warm compresses and lid scrubbing

Exclusion Criteria

Patients with blepharitis other than posterior one
Patients with other inflammatory lid conditions like atopic blepharoconjunctivitis
Patients with traumatic eyelid injuries
Patients with neoplastic lid disorders
Pregnant, conceiving and lactating females
history of any allergy to the study drugs
Patients treated with oral or topical medications other than study drugs for posterior blepharitis within 3 months period

Study & Design

• Study Type: interventional
• Study Design: Not specified